Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer
Thomas M. Campbell, Mauro A. A. Castro, Kelin Gonçalves de Oliveira, et al.
Cancer Research (2017) Vol. 78, Iss. 2, pp. 410-421
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Role of RNA modifications in cancer
Isaia Barbieri, Tony Kouzarides
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 303-322
Closed Access | Times Cited: 928
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Paz Nombela, Borja Miguel‐López, Sandra Blanco
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 355
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez, Yusheng Zhang, Yuichiro Nakata, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 331
Fibroblast growth factor receptors as treatment targets in clinical oncology
Masaru Katoh
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 105-122
Closed Access | Times Cited: 301
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 121
RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 68
Oncogenic Y‐box binding protein‐1 as an effective therapeutic target in drug‐resistant cancer
Michihiko Kuwano, Tomohiro Shibata, Kosuke Watari, et al.
Cancer Science (2019) Vol. 110, Iss. 5, pp. 1536-1543
Open Access | Times Cited: 100
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Jakub Szymczyk, Katarzyna Dominika Sluzalska, Izabela Materla, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5796-5796
Open Access | Times Cited: 61
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
Chiara Francavilla, Ciara O’Brien
Open Biology (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 37
Single-cell landscape in mammary epithelium reveals bipotent-like cells associated with breast cancer risk and outcome
Weiyan Chen, Samuel Morabito, Kai Kessenbrock, et al.
Communications Biology (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 48
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
Dominika Piasecka, Marcin Braun, Kamila Kitowska, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 47
The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells
Federica Zilli, Pedro Marques Ramos, Priska Auf der Maur, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 4
Open Access | Times Cited: 36
Revolutionizing Pathology with Artificial Intelligence: Innovations in Immunohistochemistry
Diana Gina Poalelungi, Anca‐Iulia Neagu, Ana Fulga, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 693-693
Open Access | Times Cited: 5
Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer
W. H. Tian, Lewei Zhu, Yongzhou Luo, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Targeting Phosphorylation of Y-Box–Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance
Tomohiro Shibata, Kosuke Watari, Akihiko Kawahara, et al.
Molecular Cancer Therapeutics (2019) Vol. 19, Iss. 3, pp. 882-894
Open Access | Times Cited: 40
The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
Ting Liu, Lei Sun, Zhizhao Li, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
KMT2D‐mediated H3K4me1 recruits YBX1 to facilitate triple‐negative breast cancer progression through epigenetic activation of c‐Myc
Bing Yao, Mengying Xing, Xiangwei Zeng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 4
Key epigenetic enzymes modulated by natural compounds contributes to tumorigenicity
Xiaoyue Zhou, Wanqing Liu, Ziqi Liang, et al.
International Journal of Biological Macromolecules (2025), pp. 140391-140391
Closed Access
NFIX suppresses breast cancer cell proliferation by delaying mitosis through downregulation of CDK1 expression
Haiyan Ma, Rui Sun, Tian Tian, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
YBX1 Modulates Intimal Hyperplasia by Regulating Expression and Alternative Splicing of Cell Cycle Associated Genes in RASMCs
Yi Huang, Yuheng Wang, Feng Zhu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Modifications of RNA in cancer: a comprehensive review
Shalu Ranga, Ritu Yadav, Meenakshi Chauhan, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway
Dong Ma, Pengpeng Liu, Junjun Wen, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 2, pp. 362-376
Open Access | Times Cited: 17
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility
Kohei Kumegawa, Sumito Saeki, Yōko Takahashi, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 7, pp. 1208-1222
Open Access | Times Cited: 9
KLF3 promotes colorectal cancer growth by activating WNT1
Wei Shen, Lebin Yuan, Boyu Hao, et al.
Aging (2024)
Open Access | Times Cited: 3
Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
Bo Yang, Zhihang Zhou, Li Chen, et al.
Cancer Medicine (2018) Vol. 7, Iss. 5, pp. 1756-1765
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top